ArticleLasers in medical science2025
Efficacy and prognostic factors for successful treatment of port-wine stains by 577-nm yellow laser: a cohort study on 42 patients.
Article in Lasers in medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Hemoporfin photodynamic therapy for port-wine stains in children: a prospective study.Frontiers in medicine · 2026Article
- A variable-pulse copper vapor laser at 578 nm application for the treatment of facial resistant Port wine stains: case report.Lasers in medical science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A port-wine stain (PWS) is a congenital capillary abnormality with an incidence of 0.3-0.5%. Although several other types of lasers have been used to treat PWSs, few studies have focused on the factors that affect the outcome of 577-nm yellow lasers. We aimed to assess the efficacy and prognostic factors affecting the PWS treatment by 577-nm yellow laser. This study was carried out on 42 patients with PWS. Each patient received 6-10 treatment sessions with a 577-nm yellow laser at 4-week intervals. Treatment efficacy was considered adequate when improvement of ≥ 80% of the lesion occurred. After treatment, marked improvement occurred in 7 (16.7%) patients, moderate improvement in 17 (40.5%) patients, mild improvement in 10 (23.8%) and 8 (19%) patients showed poor improvement. There was a significant association between improvement and gender of the patients and site of lesion (p = 0.028, p = 0.001, respectively). However, linear regression analysis showed that the site of the lesion can significantly predict the improvement (p < 0.001), while other baseline characteristics were not associated and cannot act as predictors for improvement. Yellow laser is a successful therapy choice for PWS, with a statistically significant improvement and minimal adverse effects. No significant association was found between improvement following laser therapy and baseline parameters, except for the location of PWS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.